Portfolio
32
companies
AUM
£50.0M
under management
Adapttech
Adapttech develops wearable biomedical technologies to improve the quality of life for people with physical limitations.
Arrow Risk Management
Arrow Risk Management provides a cloud-based underwriting platform delivering real-time data for the insurance sector.
Axis Spine Technologies
Axis Spine Technologies develops the next generation of modular anterior spinal implant technology.
BLOK
Hybrid fitness studio and digital training platform combining physical spaces with online classes.
BMLL
BMLL supplies harmonised historical market data and analytics to financial institutions.
Bio-Sep
Bio-Sep turns forestry co-products into valuable biochemical building blocks using ultrasonic technology.
BirdsEyeView
BirdsEyeView provides high speed natural catastrophe modelling for insurers using artificial intelligence and climate data.
BlackCurve
BlackCurve provides pricing optimisation software for ecommerce businesses.
Cumulus Neuroscience
Digital biomarker platform provider for neuroscience clinical trials and patient monitoring.
FLIT
FLIT designs and manufactures lightweight folding electric bicycles for urban commuters.
HUBX
HUBX operates a digital deal syndication platform for banks and brokerage firms.
Hammer Missions
Hammer Missions develops automated drone software for building inspections.
Howbout
Howbout develops a social planning application that streamlines scheduling for groups of friends.
Huq Industries
Huq Industries provides mobility intelligence and footfall data to public and private sector organisations.
Konsileo
Konsileo provides a commercial insurance broking platform supported by risk management technology.
Kuano
Kuano combines quantum mechanics and AI to design targeted enzyme inhibitors.
Monterosa
Monterosa delivers a real time engagement platform for sport and entertainment brands.
NumberEight
NumberEight uses on device artificial intelligence to enable privacy first audience targeting for advertisers.
OneID
OneID provides bank-verified digital identity and age verification services.
Orthofuse
Orthofuse develops 3D-printed implants that surgeons can adjust during procedures.
Oxford Drug Design
Oxford Drug Design develops novel cancer therapeutics using a proprietary computational and machine learning platform.
Oxford Medical Simulation
Oxford Medical Simulation builds virtual reality platforms for healthcare training.
Reboxed
Reboxed provides recommerce solutions for retailers and businesses to trade pre-owned technology.
Scene Group
Scene Group develops animation software for motion designers.
Silveray
Silveray develops novel X-ray conversion materials for safer and more efficient imaging.
Singular Photonics
Developer of intelligent image sensors that count individual photons.
SnapDragon Monitoring
SnapDragon Monitoring provides digital brand protection tools to identify and remove counterfeit goods.
Sonichem
Sonichem transforms waste sawdust into sustainable biochemical alternatives to petrochemicals.
Spotta
Spotta creates connected monitoring devices for insect pest management across various industries.
Teal
Teal provides payroll data and financial solutions for the credit industry.
Unum Aircraft Seating
Unum Aircraft Seating manufactures sustainable and lightweight seats for business class cabins.
Veremark
Veremark operates a digital platform for global background screening and employee conduct risk management.
The oversubscribed round will fund a next-generation sensor tape-out and team expansion following a surge in sales.
"We’ve already doubled our 2025 sales, we’re approaching break-even, and our customers are telling us exactly what they want from future product"
The round was led by a group of angel investors to support technical development and regulatory readiness.
"The main pain point here is that orthopaedic trauma and spinal degenerative conditions are technically demanding, time-sensitive, and extremely challenging when there is poor bone quality. Current implant systems struggle to comprehensively meet the needs of the patient and the surgeon. The inherent limitations cause prolonged surgical times and increased risks to the patient."
The Series B round was led by Gresham House Ventures and includes debt financing from Salica Partners.
"The world of work is facing a new set of challenges."
The investment was led by Whiterock with participation from regional funds and angel backers.
"There is a substantial unmet need today in neuroscience clinical studies. Many study endpoints are measured with traditional pen and paper assessments which lack objective data about brain function. Biopharma companies need objective data to effectively establish baseline information about whether a drug is engaging with the region of the brain that a particular drug is targeting, whether a drug is effective, and informing which cohort of patients may benefit the most from a particular drug."
Passion Capital led the pre-seed round, which will fund team expansion and integration partnerships across the UK and Europe.
